The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.

La-Urshalar Brock, FNP-BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in patients with breast cancer. To effectively manage ...

Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...

Although chemotherapy is an effective cancer treatment, it's not recommended for everyone. While most individuals with cancer are offered chemotherapy as part of their treatment plan, there are times ...

A total of 446 patients from 136 oncology centers in Japan with HER2-positive MBC (57.6% hormone receptor positive) and no prior chemotherapy in the metastatic setting were randomly assigned to ...

Doctors have used chemotherapy (chemo) to treat cancer since the 1940s. The advantage of these drugs is they kill cancer cells throughout your body. One downside is the side effects they can ...